Skip to main content

Table 5 Common toxicity criteria among all patients after neoadjuvant chemotherapy

From: Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial

Variable

Chemotherapy toxicity

 

N

%

Fatigue

40

88.9

Alopecia

38

84.4

Arthralgia and myalgia

8

17.8

Diarrhoea

5

11.1

Mouth sores

4

8.9

Febrile neutropenia

3

6.7